You're signed outSign in or to get full access.
Pfizer Inc.
Pfizer Inc. is a global pharmaceutical and biotechnology corporation headquartered in New York City, United States. Founded in 1849, Pfizer develops and produces a wide range of medicines and vaccines for both human and animal health. It is one of the world's largest research-based pharmaceuticals companies, with expertise spanning cardiovascular, metabolic, infectious, respiratory diseases, oncology, and more. Pfizer employs tens of thousands worldwide and serves healthcare providers, patients, and partners globally through a vast operational footprint, including its Manhattan Hudson Yards headquarters and dozens of international locations.
Investment Strategy
Pfizer does not operate as a traditional investment fund. As a major pharmaceutical company, its strategy focuses on discovery, development, manufacturing, and commercialization of innovative prescription medicines and vaccines. The company invests heavily in R&D, seeking breakthroughs that address unmet medical needs, and often partners with biotechs, academic institutions, and global organizations. Pfizer prioritizes therapeutic areas with significant impact, such as oncology, vaccines, cardiovascular, and rare diseases, balancing internal pipeline innovation with business development, acquisitions, and collaborations to maximize growth and value for stakeholders.
Latest 13F Filing Activity
Pfizer Inc. filed their most recent 13F report on Jun 30, 2025 disclosing 21 equity positions with a total 13F market value of $576M. The fund increased holdings in Biontech SE, Oric Pharmaceuticals Inc., Spero Therapeutics Inc. among other positions. Pfizer Inc. reduced exposure to Allogene Therapeutics Inc., Biohaven LTD, Wave Life Sciences LTD among others.
Top Holdings
Equity Positions (21)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
B BNTX | BIONTECH SE | 67.60% | $389.5M | 3,658,361 | $113.95 | $106.47 | +$56.4M |
O ORIC | ORIC PHARMACEUTICALS INC | 9.47% | $54.6M | 5,376,344 | $8.07 | $10.15 | +$24.6M |
A ARVN | ARVINAS INC | 4.42% | $25.4M | 3,457,815 | $19.17 | $7.36 | +$1.2M |
A ALLO | ALLOGENE THERAPEUTICS INC | 4.32% | $24.9M | 22,032,040 | $2.13 | $1.13 | -$7.3M |
T TRML | TOURMALINE BIO INC | 3.53% | $20.3M | 1,272,214 | $20.28 | $15.99 | +$992.3K |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more